| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA | SVP, General Counsel | Common Stock | 9,605 | $4.03 M | $419.07 | Aug 15, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Aug 15, 2022 | 6 | -1,138,723 | 4 | Aug 17, 2022 | SVP, General Counsel |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Aug 10, 2022 | 1 | -10,812 | 4 | Aug 12, 2022 | SVP, General Counsel |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Aug 9, 2022 | 1 | -283,800 | 4 | Aug 10, 2022 | SVP, General Counsel |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | May 16, 2022 | 5 | -33,633 | 4 | May 18, 2022 | SVP, General Counsel |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Apr 29, 2022 | 5 | -33,049 | 4 | May 3, 2022 | SVP, General Counsel |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Feb 24, 2022 | 1 | -354,094 | 4 | Feb 28, 2022 | SVP, General Counsel |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Feb 17, 2022 | 1 | -165,547 | 4 | Feb 22, 2022 | SVP, General Counsel |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Feb 10, 2022 | 1 | -112,689 | 4 | Feb 14, 2022 | SVP, General Counsel |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Feb 1, 2022 | 3 | 0 | 4 | Feb 3, 2022 | SVP, General Counsel |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | May 17, 2021 | 2 | -24,230 | 4 | May 19, 2021 | SVP, General Counsel |